- Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in IndiaPosted on by Pascale BouchardinCorporate
- Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic AlopeciaPosted on by Pascale BouchardinCorporate
- Triple Hair’s Feature in the NY PostPosted on by Pascale BouchardinIn the medias
- Triple Hair Group Signs Licensing Agreement for the Brazilian Market with AchéPosted on by Pascale BouchardinCorporate
- Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of DirectorsPosted on by Pascale BouchardinCorporate
- TH07 Clinical Study Featured in Peer-Reviewed Scientific JournalPosted on by Pascale BouchardinScience
- Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in IndiaPosted on by Pascale BouchardinCorporate
- Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in EuropePosted on by Pascale BouchardinCorporate
- Triple Hair’s Feature in Le Journal de MontréalPosted on by Pascale BouchardinIn the medias
- Triple Hair Group Closes $4 Million FinancingPosted on by Pascale BouchardinCorporate&In the medias
